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Low concentrations of maternal thyroxin during early gestation:
a risk factor of breech presentation?
Victor J. Pop,a Evelien P. Brouwers,a Hennie Wijnen,a Guid Oei,b
Gerard G. Essed,c Huib L. Vaderd
Objective To evaluate the relation between breech position at term (> 37 weeks of gestation) and low
maternal fT4 levels during gestation in women not suffering from overt thyroid dysfunction.
Design A prospective cohort study of pregnant women.
Setting Community-based study.
Population/Sample At random selected pregnant women of the general population.
Methods At antenatal booking, based on thyroid function assessed at 12 weeks of gestation in a large cohort
of pregnant women, two groups of participants were defined: women with low fT4 levels—below the
10th centile (n ¼ 135) and women with fT4—between the 50th and 90th centiles at 12 weeks of gestation
(n ¼ 135). Women with clinical thyroid dysfunction (fT4 and TSH outside reference range) at 12 weeks
of gestation were excluded. Maternal thyroid function (fT4 and TSH) was subsequently assessed at 24 and
32 weeks of gestation. Analysis refers to 204 women who met the inclusion and exclusion criteria and in
whom all thyroid parameters were assessed.
Main outcome measures Fetal presentation (cephalic–breech) at delivery in women with term gestation
(>37 weeks of gestation) in relation to maternal thyroid function at 12, 24 and 34 weeks of gestation.
Results Breech presentation at term delivery was independently related to fT4 levels <10th centile at 12
weeks of gestation (OR ¼ 4.7, 95% CI 1.1–19 [but not to an fT4 level below the 10th centile at 24 and 32
weeks of gestation]) as well as primiparity (OR ¼ 4.7, 95% CI 1.3–15).
Conclusions Women with hypothyroxinaemia (fT4 level at the lowest 10th centile) during early gestation but
without overt thyroid function are at risk for fetal breech presentation at term (>37 weeks of gestation).
INTRODUCTION
Approximately 3–5% of all pregnancies reach term with
the fetus in the breech position.1 In general, it is believed
that breech deliveries are associated with higher morbidity
and mortality, especially after vaginal delivery. Recently, a
large, randomised, controlled multicentre trial showed an
odds ratio (OR) of 0.33, with regard to perinatal mortality,
neonatal mortality and serious neonatal morbidity, in fetus
who presented in the breech position and who were
delivered by caesarean section, compared with those who
had a planned vaginal delivery.2 It was questioned whether
there is still a place for planned vaginal breech birth, and
primary caesarean section was advocated for all breech term
presentations, which was however criticised by others.3 In
general, caesarean section still has an increased maternal
mortality rate compared with non-operative delivery4 and
has been estimated to double the costs for health care dur-
ing the first two postpartum months.5 External version to
cephalic position substantially reduces breech presentations
although serious fetal and obstetric complications have
been described. It has been calculated that six attempted
external cephalic version are needed to avoid one caesarean
section because of breech position.6
The negative impact of maternal hypothyroxinaemia
(low free thyroid hormone concentration [fT4] with thyrot-
rophin hormone [TSH] concentration within the reference
range) during early gestation on subsequent infant devel-
opment at one and two years of age has recently been
demonstrated.7 At one and two years of age, children of
women with hypothyroxinaemia showed an 8- to 10-point
index delay on the motor scale compared with children of
women with fT4 between the 50th and 90th centiles.
Because the fetus does not produce its own thyroxin up
until 16–20 weeks of gestation, it is totally dependent on
the maternal supply of fT4 during the first trimester of
pregnancy.8 Thyroid hormone is extremely important for
the development of the fetal central nervous system: overt
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maternal hypothyroidism during pregnancy or major iodine
(a major keystone of thyroid hormone synthesis) deficiency
has been associated with the poor obstetric and develop-
mental outcome of the infant.9
Little is known about the aetiology of breech presenta-
tion. Together, factors such as prematurity, intrauterine
growth retardation, gemelli, pelvic abnormalities, as well
as uterus anomalies, placenta praevia, polyhydramnios,
multiparity, umbilical cord problems and congenital fetal
abnormalities only explain 15% of breech presentations.10
However, there are several aetiological factors (umbilical
cord problems, congenital akinesia syndrome) that might be
related to fetal movements during pregnancy.11,12 It is
interesting to note that, in a few congenital endocrinolog-
ical syndromes (Prader–Willi, pituitary agenesis) in which
hypothalamic function is impaired (and, as a consequence,
fetal thyroid function), the rate of breech presentations is
very high: up to 20%.13
We hypothesised that motor development retardation in
children at one and two years of age—if related to maternal
hypothyroxinaemia during early gestation—should also be
present during gestation. Because abnormal fetal movements
could be related to breech presentation, we questioned
whether breech presentation at term gestation was related
to maternal hypothyroxinaemia during early gestation and
the subsequent course of maternal thyroxin concentrations
throughout pregnancy.
METHODS
Between January 1997 and April 1998, all pregnant
women (n ¼ 1881), living in and around the city of
Eindhoven, the Netherlands, were invited to participate
into the study at their first antenatal control with a com-
munity midwife (Fig. 1). Only Dutch Caucasian women
(n ¼ 1722) were eligible of whom 1361 (79%) con-
sented to participate. Thyroid parameters (TSH, fT4 and
TPO-Ab) were assessed at 12 weeks of gestation. Be-
cause of ethical reasons, women with overt hyperthyroid-
ism (n ¼ 7) and hypothyroidism (n ¼ 1) were sent to their
general practitioner with an advise for treatment and
were excluded. In the first 220 of the remaining 1353
women, the lowest 10th and the 50th–90th fT4 centiles
Fig. 1. Flowchart of inclusion and exclusion of women during follow up in pregnancy.
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were calculated within the first 10 weeks of inclusion: 12.1
and 15.4–19.0 pmol/L, respectively. Thereafter, a further
calculation was performed after every consecutive 150
women, which, after minor changes, resulted in the final
cutoff scores for the total sample for the 10th (12.4 pmol/L)
and 50th–90th (15.6–19.1 pmol/L) centiles. The 135
women in the lowest fT4 centile were matched for parity
and gravidity with an equal number of women whose
fT4 values were between the 50th and 90th centiles. All
these women (n ¼ 270) were invited to participate in a
follow up study (Fig. 1). Twelve declined to participate,
and 20 were excluded, based on previously determined
exclusion criteria (fertility problems; presence of auto-
immune diseases such as rheumatoid arthritis or insulin-
dependent diabetes mellitus). The remaining 238 women
were visited at home at 24 and 32 weeks of gestation
for repeated assessments of thyroid function and gesta-
tional complications. No thyroid parameters were noted
in 21 women at 24 and/or 32 weeks of gestation. Thir-
teen women with obstetric complications such as abor-
tion, gemelli pregnancy and preterm delivery (<37 weeks
of gestation) were excluded. Therefore, analysis of the
data covers 204 women. The characteristics of these
women (demographic features, lifestyle habits, obstetric
and thyroid parameters) for the group as a whole are shown
in Table 1.
This study was approved by the Medical Ethical
Committee of Maxima Medical Centre Eindhoven (the
Netherlands).
TSH (reference range for women aged between 20 and
40 years: 0.15–2.0 mIU/L) was measured using a solid-
phase, two-site, chemiluminescent enzyme immunometric
assay (IMMULITE third generation TSH, Diagnostic Cor-
poration, Los Angeles, California). The inter-assay coef-
ficients of variation were 9.8%, 6.9% and 4.6%, at
concentrations of 0.02, 0.15 and 11 mIU/L, respectively.
The fT4 concentration (reference range for women aged
between 20 and 40 years: 8.7–19.6 pmol/L) was also
measured by means of a solid-phase immunometric assay
(IMMULITE Free T4). The inter-assay coefficients of
variation for this technique were 20%, 5.3% and 5.2% at
concentrations of 3.1, 19.8, and 55 pmol/L, respectively.
Subclinical thyroid dysfunction was defined by an fT4
within reference range with abnormal TSH, while clinical
thyroid dysfunction was defined by both fT4 and TSH
levels outside reference range. The IMMULITE anti-TPO
Ab kit was used to determine antibodies against thyroid
peroxidase (TPO). The inter-assay coefficients of variation
for this analysis were 19.9%, 13.0% and 13.4% for con-
centrations of 36, 69 and 114 IU/mL, respectively. The
anti-TPO assay was standardised according to the Interna-
tional Reference Preparation for anti-TPO MRC 66/387. A
concentration of between 35 and 100 IU/mL was regarded
as being moderately elevated, while one of >100 IU/mL as
being clearly elevated. Because of the down-regulation of
the immune system during pregnancy (as reflected by
decreasing titers of antibodies), TPO-Ab was only assessed
at 12 weeks of gestation.
During late gestation (>37 weeks of gestation) as well as
at delivery, a careful assessment and registration of fetal
position was carried out.
Statistical analysis was performed using the Statistical
Package of Social Science and Problems Solutions (SPSS).
Differences in characteristics between the various sub-
groups were analysed by means of the m2 test. ORs (with
95% CI) were calculated by means of multiple logistic
regression analysis.













low (<US$25,000) 31 (15)
middle (<US$40,000) 69 (34)
high (>US$40,000) 88 (43)
unknown 16 (8)
Lifestyle habits during pregnancy
Smoking 45 (22)






Mean gestational age, weeks [SD] 39.8 [1.4]
Manner of delivery
spontaneous at home 92 (45)
spontaneous in hospital 47 (23)
after induction vaginally 20 (10)
forceps/vacuum 26 (13)
caesarean section 19 (9)




Subclinical hypothyroidism during gestation at
12 weeks 35 (17)
24 weeks 26 (13)
32 weeks 21 (10)
Subclinical hyperthyroidism during gestation at
12 weeks 6 (3)
24 weeks –
32 weeks –
Elevated TPO-Ab titre at 12 weeks of gestation
>35 IU/mL 22 (11)
100 IU/mL 14 (7)
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RESULTS
At 12 weeks of gestation, there were 6 (3%) women with
subclinical hyperthyroidism and 35 (17%) with subclinical
hypothyroidism, 22 (11%) women had TPO-Ab titres >35
IU/mL and 14 (7%) >100 IU/mL (Table 1). At 24 and
32 weeks of gestation, there were 26 (13%) and 21 (10%)
women with subclinical hypothyroidism, respectively. No
women with subclinical hyperthyroidism were found at
24 and 32 weeks of gestation.
At term gestation (>37 weeks of gestation), 12 women
showed fetal position in breech presentation (of whom in
one of them cephalic position was reached after external
version at 38 weeks of gestation). Of these 12 women, 10
(85%) belonged to the subjects with an fT4 <10th centile at
12 weeks of gestation and 2 (15%) to the controls with an
fT4 between 50 and 90th centiles at 12 weeks of gestation
(P ¼ 0.03, m2 ¼ 4.7, df ¼ 1). Three of the women with fetal
breech presentation had a spontaneous vaginal delivery,
one women (after external version in cephalic position at 38
weeks of gestation) delivered by vacuum extraction vagi-
nally and the remaining eight delivered by elective caesar-
ean section. In Table 2, the relation between breech
presentation at term gestation (>37 weeks) and several
independent variables is shown using univariate logistic
regression analysis (OR, 95% CI). The risk of breech
presentation at term gestation proved to be increased more
than fourfold in those women with an fT4 <10th centile at
12 weeks of gestation (OR ¼ 4.7, 95% CI 1.1–19) while
low fT4 levels at 24 and 32 weeks of gestation were not
related to fetal position at term (OR ¼ 3.4, 95% CI 0.8–14
and OR ¼ 1.9, 95% CI 0.4–9.5, respectively). Subclinical
hypo- as well as hyperthyroidism was not related to breech
position. Primiparity increased the risk for breech presen-
tation threefold (OR ¼ 3.0, 95% CI 1.1–10). Finally, in
Table 3, multiple logistic regression showed that breech
presentation at term gestation proved to be independently
related to low fT4 levels at 12 weeks of gestation as well as
to primiparity (OR ¼ 5.1, 95% CI 1.2–22 and OR ¼ 4.7,
95% CI 1.3–15, respectively).
DISCUSSION
As far as we know, this is the first study to be pub-
lished that investigates the relationship between maternal
thyroid hormone levels in women with no overt thyroid
dysfunction during pregnancy and subsequent obstetric
outcome. Women with low levels of fT4 (defined as the
lowest 10th centile of fT4 at 12 weeks of gestation) were at
high risk of being able to reach term with a child in the
breech position, and consequently, of having to deliver by
caesarean section.
Overt maternal hypothyroidism is well documented as
being related to obstetric complications.9 However, it is a
rare condition in childbearing women. Moreover, because
hypothyroidism often is associated with fertility problems
(due to anovulation), most women with overt hypothy-
roidism only become pregnant after adequate substitution
with thyroid hormone. Most women—at least in iodine-
supplemented areas—who present with overt hypothy-
roidism during pregnancy have been inadequately treated
Table 2. Factors associated with breech presentation at term analysis of
204 women. Dependent variable: breech presentation at term gestation
(>37 weeks), method enter.
OR 95% CI
Primiparity 3.0 1.1–10
Caffeine consumption 1.3 0.3–4.8
Smoking 1.9 0.8–4.9
Alcohol consumption 1.1 0.4–4.6
Low income 1.2 0.5–5.1
Low education 1.1 0.3–3.1
fT4 < 10th centile
At 12 weeks 4.7 1.1–19
At 24 weeks 3.4 0.8–14
At 32 weeks 1.9 0.4–9.5
Subclinical hypothyroidism
At 12 weeks 1.2 0.2–5.8
At 24 weeks 1.4 0.3–6.7
At 32 weeks 1.8 0.4–7.1
Subclinical hyperthyroidism
At 12 weeks 1.1 0.4–1.9
TPO-Ab > 35 IU/mL at 12 weeks 1.4 0.2–6.1
TPO-Ab > 100 IU/mL at 12 weeks 1.1 0.1–4.7
Table 3. Factors affecting breech presentation at term analysis of 204




Caffeine consumption 1.1 0.2–3.7
Smoking 1.9 0.4–3.6
Alcohol consumption 1.2 0.4–5.1
Low income 1.1 0.3–3.1
Low education 1.1 0.6–3.7
fT4 < 10th centile
At 12 weeks 5.1 1.2–22
At 24 weeks 2.7 0.9–18
At 32 weeks 1.7 0.2–14
Subclinical hypothyroidism
At 12 weeks 1.2 0.2–18
At 24 weeks 1.3 0.3–22
At 32 weeks 1.1 0.1–19
Subclinical hyperthyroidism
At 12 weeks 1.2 0.2–22
TPO-Ab > 35 IU/mL at 12 weeks 1.1 0.1–16
TPO-Ab > 100 IU/mL at 12 weeks 1.2 0.2–19
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(inadequate substitution of thyroid hormone in those with
previous hypothyroidism, or inadequate treatment with
anti-thyroid drugs in those who were suffering from
hyperthyroidism).
The mechanism that could explain the association be-
tween maternal hypothyroxinaemia and an increased rate of
breech deliveries still remains to be explained. However, it
could be hypothesised that adequate fetal movement is
important for reaching a cephalic position. Moreover, it
could also be hypothesised that adequate fetal movement
interferes with the development of a long enough umbilical
cord, which, when it is too short, has been associated with
an increased rate of the breech position.11,12 As has been
demonstrated recently, during early pregnancy, hypothyrox-
inaemic women are at risk of conceiving children with
clear motor development retardation at one and two years
of age.7 It is reasonable to suppose that, if this is due to the
fetus’s early (i.e. before the fetus produces its own thy-
roid hormone, which is generally not until 16 weeks of
gestation) shortage of thyroid hormone during pregnancy,
a possible detrimental effect on motor development is
already present during gestation. It is interesting to note
that, in a number of congenital endocrinological syndromes
(Prader–Willi, pituitary agenesis) in which hypothalamic
function is impaired (and, as a consequence, fetal thyroid
function), the rate of breech presentations is extremely
high: up to 20%.13
The direct echo graphical assessment of fetal movements
has recently been developed.14,15 However, the standard
procedure is to assess fetal movements for a period of at
least 40–60 minutes. Up until now, it has not been
ascertained whether such long-duration echo graphical
examinations have any negative effects on the fetus, which
makes it difficult to use this instrument as a standard
research tool for assessing fetal movement. It has been
suggested that maternal hypothyroxinaemia might be relat-
ed to inadequate iodine intake during pregnancy.16,17 How-
ever, the present study was carried out in an area in which
the general population has an adequate intake of iodine,
although it is still a matter of speculation whether adequate
iodine intake in non-childbearing women also guarantees
adequate intake of iodine during pregnancy. In this regard,
data on iodine intake in large samples of pregnant women
are certainly warranted.
Several limitations of the present study need to be
mentioned. Firstly, the rather low number of women
undergoing breech deliveries. Because statistically signifi-
cant differences were found in rather small numbers in the
present study, larger studies with more epidemiological
power are needed in order to confirm the association
between maternal hypothyroxinaemia and the breech posi-
tion. Only then can interventional trials with thyroxin
replacement possibly be considered. Secondly, after screen-
ing of a large sample, only women with two well-defined
ranges of thyroid hormone concentration (<10th vs 50–90th
centile) were included for reasons that have been published
elsewhere.7 Preferentially, the relation between thyroid
hormone and breech position should be investigated in a
large open pregnant population in which fT4 is equally
distributed and thyroid function is assessed at different times
during gestation.
During the last decade, a debate has generated which
questions whether thyroid parameters (TSH, fT4 and thyroid
peroxidase antibodies, TPO-Ab) should be screened in all
pregnant women.18,19 The association between elevated
concentrations of TPO-Ab and an increased rate of abortion,
the high correlation between elevated TPO-Ab and the
development of postpartum thyroiditis and the relationship
between maternal hypothyroxinaemia and impaired infant
development are all arguments in favour of screening. The
possible role of—what is up until now conceived as phys-
iologically—low concentrations of maternal thyroid hor-
mone (in euthyroid women) in obstetric outcome may be
another argument in favour of screening, especially when
one realises that true hypothyroxinaemia (fT4 below the 10th
centile with normal TSH levels) refers to 5–7% of the
general pregnant population. Practically, screening would
be easy to implement in Western societies: all pregnant
women have blood samples taken between 12 and 16 weeks
of gestation. However, until one of the main criteria for
screening is met (i.e. is there any evidence of an effective
treatment with a realistic cost/benefit ratio?), we feel that
screening should not yet be endorsed.
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